Milestone Pharmaceuticals (MIST) PT Lowered to $17 at Oppenheimer
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Price: $1.63 --0%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 16
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 17 | New: 16
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on Milestone Pharmaceuticals (NASDAQ: MIST) to $17.00 (from $18.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Feng Tay Enterprises (9910:TT) to Hold
- Lithium Americas Corp. (LAC:CN) (LAC) PT Lowered to Cdn$5.10 at HSBC
- KDDI Corp. (9433:JP) (KDDIY) PT Lowered to JPY4,520 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
